The case for infectious endocarditis prophylaxis: time to move forward.
Seto
Todd B
TB
Center for Outcomes Research and Evaluation, The Queen's Medical Center, and Division of Cardiology, Department of Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii, USA. tseto@queens.org
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D003731:Dental Caries / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D004697:Endocarditis, Bacterial / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D009017:Morbidity / Q000639:trends; D011379:Prognosis; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents